Curative treatment that eliminates
hepatitis C virus (HCV) from the body can reduce central fatigue, one of the most concerning
symptoms associated with chronic hepatitis C, according to research presented at the 49th annual meeting of the European Association for the Study of the Liver (EASL), held recently in London.
is a common and debilitating symptom for many people with hepatitis C. Central
fatigue refers to weakness originating in the central nervous system (the brain
and spinal cord), as opposed to peripheral or physical fatigue that originates
in the muscles.
is also a common side-effect of treatment with interferon and ribavirin.
Ribavirin often causes anaemia, which can
lead to fatigue by reducing the blood’s capacity to carry oxygen. New direct-acting antiviral agents allow
people with hepatitis C to either take interferon or ribavirin for a shorter
duration or to avoid them altogether.